Article

ASCRS names Stephen H. Speares executive director

The American Society of Cataract and Refractive Surgery’s (ASCRS) Executive Committee announced that Stephen H. “Steve” Speares will serve as the society’s next executive director, according to a prepared statement.

The American Society of Cataract and Refractive Surgery’s (ASCRS) Executive Committee announced that Stephen H. “Steve” Speares will serve as the society’s next executive director, according to a prepared statement.

Speares replaces David Karcher, who retired after leading ASCRS for 38 years.

“Steve’s breadth of experience, excellent leadership skills, solid understanding of ophthalmology and pioneering spirit will take ASCRS to new heights,” said Karcher in the statement.

“I am excited to lead ASCRS and build on Dave’s incredible track record of leadership, dedication to ophthalmology and unwavering commitment to those in the profession,” said Speares in the statement. 

“As we move into this new era, I look forward to leveraging the society’s founding vision, rooted in innovation, to identify new opportunities to increase the value ASCRS brings to anterior segment surgeons, and the patients they serve,” he said.

Speares, who is currently vice president, Europe and Middle East at Glaukos, will formally begin his role in April 2018, at the ASCRS annual meeting in Washington, DC. Previously, he worked at Alcon Laboratories, where he held a variety of operational positions during his 18 years there.

Karcher will stay on in an advisory role to the association until the transition is complete.

 

 

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.